Tauriga Sciences, Inc. announced plans to commence development of a pharmaceutical grade version of Tauri-Gum™. The Company’s vision is to develop a pharmaceutical product, based off of the Tauri-Gum™ platform, that focuses on the potential anti-nausea properties of Cannabinoids. While this process is preliminary at this stage, the Company believes that a potentially viable roadmap exists, to achieve this corporate initiative. The Company will continually update its shareholders, via future press releases, should material progress be realized. There can be no guarantee that the Company will ultimately be successful, in developing any type of Pharmaceutical product(s).